Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer

Autor: Moses, Marcus, Niu, Alex, Lilly, Michael B., Hahn, Andrew W., Nussenzveig, Roberto, Ledet, Elisa, Manogue, Charlotte, Cotogno, Patrick, Lewis, Brian, Layton, Jodi, Agarwal, Neeraj, Sartor, Oliver, Barata, Pedro C.
Zdroj: In Cancer Treatment and Research Communications 2020 24
Databáze: ScienceDirect